Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
Status:
Completed
Trial end date:
2017-06-08
Target enrollment:
Participant gender:
Summary
This is a phase I study to evaluate the safety, tolerability and pharmacokinetics of Icotinib
Hydrochloride Cream in patients with mild to moderate psoriasis.